ESR1 and breast cancer: Triple-negative breast cancer (TNBC), which represents approximately 15% of all breast cancers, is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and erb-b2 receptor tyrosine kinase 2 (ERBB2/HER2) expression [2].